Click for best price
Insulin Glargine Injection Market Size, Share 2024
The global Insulin Glargine Injection market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Pre-filled Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Insulin Glargine Injection include Sanofi, Lilly, Gan & Lee, Tonghua Dongbao Pharmaceutical, HEC Pharm and Boao Bio Harmaceutical, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Insulin Glargine Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Glargine Injection. This report contains market size and forecasts of Insulin Glargine Injection in global, including the following market information:
Global Insulin Glargine Injection Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Insulin Glargine Injection Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Insulin Glargine Injection companies in 2023 (%)
We has surveyed the Insulin Glargine Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Insulin Glargine Injection Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Insulin Glargine Injection Market Segment Percentages, by Type, 2023 (%)
Pre-filled
Ordinary
Global Insulin Glargine Injection Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Insulin Glargine Injection Market Segment Percentages, by Application, 2023 (%)
Hospital
Clinic
Global Insulin Glargine Injection Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Insulin Glargine Injection Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Insulin Glargine Injection revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Insulin Glargine Injection revenues share in global market, 2023 (%)
Key companies Insulin Glargine Injection sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Insulin Glargine Injection sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Lilly
Gan & Lee
Tonghua Dongbao Pharmaceutical
HEC Pharm
Boao Bio Harmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Insulin Glargine Injection, market overview.
Chapter 2: Global Insulin Glargine Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Insulin Glargine Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Insulin Glargine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Insulin Glargine Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Insulin Glargine Injection Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
74 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Insulin Glargine Injection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insulin Glargine Injection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Insulin Glargine Injection Overall Market Size
2.1 Global Insulin Glargine Injection Market Size: 2023 VS 2030
2.2 Global Insulin Glargine Injection Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Insulin Glargine Injection Sales: 2019-2030
3 Company Landscape
3.1 Top Insulin Glargine Injection Players in Global Market
3.2 Top Global Insulin Glargine Injection Companies Ranked by Revenue
3.3 Global Insulin Glargine Injection Revenue by Companies
3.4 Global Insulin Glargine Injection Sales by Companies
3.5 Global Insulin Glargine Injection Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Insulin Glargine Injection Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Insulin Glargine Injection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Insulin Glargine Injection Players in Global Market
3.8.1 List of Global Tier 1 Insulin Glargine Injection Companies
3.8.2 List of Global Tier 2 and Tier 3 Insulin Glargine Injection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Insulin Glargine Injection Market Size Markets, 2023 & 2030
4.1.2 Pre-filled
4.1.3 Ordinary
4.2 By Type - Global Insulin Glargine Injection Revenue & Forecasts
4.2.1 By Type - Global Insulin Glargine Injection Revenue, 2019-2024
4.2.2 By Type - Global Insulin Glargine Injection Revenue, 2025-2030
4.2.3 By Type - Global Insulin Glargine Injection Revenue Market Share, 2019-2030
4.3 By Type - Global Insulin Glargine Injection Sales & Forecasts
4.3.1 By Type - Global Insulin Glargine Injection Sales, 2019-2024
4.3.2 By Type - Global Insulin Glargine Injection Sales, 2025-2030
4.3.3 By Type - Global Insulin Glargine Injection Sales Market Share, 2019-2030
4.4 By Type - Global Insulin Glargine Injection Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Insulin Glargine Injection Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Insulin Glargine Injection Revenue & Forecasts
5.2.1 By Application - Global Insulin Glargine Injection Revenue, 2019-2024
5.2.2 By Application - Global Insulin Glargine Injection Revenue, 2025-2030
5.2.3 By Application - Global Insulin Glargine Injection Revenue Market Share, 2019-2030
5.3 By Application - Global Insulin Glargine Injection Sales & Forecasts
5.3.1 By Application - Global Insulin Glargine Injection Sales, 2019-2024
5.3.2 By Application - Global Insulin Glargine Injection Sales, 2025-2030
5.3.3 By Application - Global Insulin Glargine Injection Sales Market Share, 2019-2030
5.4 By Application - Global Insulin Glargine Injection Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Insulin Glargine Injection Market Size, 2023 & 2030
6.2 By Region - Global Insulin Glargine Injection Revenue & Forecasts
6.2.1 By Region - Global Insulin Glargine Injection Revenue, 2019-2024
6.2.2 By Region - Global Insulin Glargine Injection Revenue, 2025-2030
6.2.3 By Region - Global Insulin Glargine Injection Revenue Market Share, 2019-2030
6.3 By Region - Global Insulin Glargine Injection Sales & Forecasts
6.3.1 By Region - Global Insulin Glargine Injection Sales, 2019-2024
6.3.2 By Region - Global Insulin Glargine Injection Sales, 2025-2030
6.3.3 By Region - Global Insulin Glargine Injection Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Insulin Glargine Injection Revenue, 2019-2030
6.4.2 By Country - North America Insulin Glargine Injection Sales, 2019-2030
6.4.3 US Insulin Glargine Injection Market Size, 2019-2030
6.4.4 Canada Insulin Glargine Injection Market Size, 2019-2030
6.4.5 Mexico Insulin Glargine Injection Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Insulin Glargine Injection Revenue, 2019-2030
6.5.2 By Country - Europe Insulin Glargine Injection Sales, 2019-2030
6.5.3 Germany Insulin Glargine Injection Market Size, 2019-2030
6.5.4 France Insulin Glargine Injection Market Size, 2019-2030
6.5.5 U.K. Insulin Glargine Injection Market Size, 2019-2030
6.5.6 Italy Insulin Glargine Injection Market Size, 2019-2030
6.5.7 Russia Insulin Glargine Injection Market Size, 2019-2030
6.5.8 Nordic Countries Insulin Glargine Injection Market Size, 2019-2030
6.5.9 Benelux Insulin Glargine Injection Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Insulin Glargine Injection Revenue, 2019-2030
6.6.2 By Region - Asia Insulin Glargine Injection Sales, 2019-2030
6.6.3 China Insulin Glargine Injection Market Size, 2019-2030
6.6.4 Japan Insulin Glargine Injection Market Size, 2019-2030
6.6.5 South Korea Insulin Glargine Injection Market Size, 2019-2030
6.6.6 Southeast Asia Insulin Glargine Injection Market Size, 2019-2030
6.6.7 India Insulin Glargine Injection Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Insulin Glargine Injection Revenue, 2019-2030
6.7.2 By Country - South America Insulin Glargine Injection Sales, 2019-2030
6.7.3 Brazil Insulin Glargine Injection Market Size, 2019-2030
6.7.4 Argentina Insulin Glargine Injection Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Insulin Glargine Injection Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Insulin Glargine Injection Sales, 2019-2030
6.8.3 Turkey Insulin Glargine Injection Market Size, 2019-2030
6.8.4 Israel Insulin Glargine Injection Market Size, 2019-2030
6.8.5 Saudi Arabia Insulin Glargine Injection Market Size, 2019-2030
6.8.6 UAE Insulin Glargine Injection Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Insulin Glargine Injection Major Product Offerings
7.1.4 Sanofi Insulin Glargine Injection Sales and Revenue in Global (2019-2024)
7.1.5 Sanofi Key News & Latest Developments
7.2 Lilly
7.2.1 Lilly Company Summary
7.2.2 Lilly Business Overview
7.2.3 Lilly Insulin Glargine Injection Major Product Offerings
7.2.4 Lilly Insulin Glargine Injection Sales and Revenue in Global (2019-2024)
7.2.5 Lilly Key News & Latest Developments
7.3 Gan & Lee
7.3.1 Gan & Lee Company Summary
7.3.2 Gan & Lee Business Overview
7.3.3 Gan & Lee Insulin Glargine Injection Major Product Offerings
7.3.4 Gan & Lee Insulin Glargine Injection Sales and Revenue in Global (2019-2024)
7.3.5 Gan & Lee Key News & Latest Developments
7.4 Tonghua Dongbao Pharmaceutical
7.4.1 Tonghua Dongbao Pharmaceutical Company Summary
7.4.2 Tonghua Dongbao Pharmaceutical Business Overview
7.4.3 Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Major Product Offerings
7.4.4 Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Sales and Revenue in Global (2019-2024)
7.4.5 Tonghua Dongbao Pharmaceutical Key News & Latest Developments
7.5 HEC Pharm
7.5.1 HEC Pharm Company Summary
7.5.2 HEC Pharm Business Overview
7.5.3 HEC Pharm Insulin Glargine Injection Major Product Offerings
7.5.4 HEC Pharm Insulin Glargine Injection Sales and Revenue in Global (2019-2024)
7.5.5 HEC Pharm Key News & Latest Developments
7.6 Boao Bio Harmaceutical
7.6.1 Boao Bio Harmaceutical Company Summary
7.6.2 Boao Bio Harmaceutical Business Overview
7.6.3 Boao Bio Harmaceutical Insulin Glargine Injection Major Product Offerings
7.6.4 Boao Bio Harmaceutical Insulin Glargine Injection Sales and Revenue in Global (2019-2024)
7.6.5 Boao Bio Harmaceutical Key News & Latest Developments
8 Global Insulin Glargine Injection Production Capacity, Analysis
8.1 Global Insulin Glargine Injection Production Capacity, 2019-2030
8.2 Insulin Glargine Injection Production Capacity of Key Manufacturers in Global Market
8.3 Global Insulin Glargine Injection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Insulin Glargine Injection Supply Chain Analysis
10.1 Insulin Glargine Injection Industry Value Chain
10.2 Insulin Glargine Injection Upstream Market
10.3 Insulin Glargine Injection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Insulin Glargine Injection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Insulin Glargine Injection in Global Market
Table 2. Top Insulin Glargine Injection Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Insulin Glargine Injection Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Insulin Glargine Injection Revenue Share by Companies, 2019-2024
Table 5. Global Insulin Glargine Injection Sales by Companies, (K Units), 2019-2024
Table 6. Global Insulin Glargine Injection Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Insulin Glargine Injection Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Insulin Glargine Injection Product Type
Table 9. List of Global Tier 1 Insulin Glargine Injection Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insulin Glargine Injection Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Insulin Glargine Injection Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Insulin Glargine Injection Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Insulin Glargine Injection Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Insulin Glargine Injection Sales (K Units), 2019-2024
Table 15. By Type - Global Insulin Glargine Injection Sales (K Units), 2025-2030
Table 16. By Application ? Global Insulin Glargine Injection Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Insulin Glargine Injection Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Insulin Glargine Injection Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Insulin Glargine Injection Sales (K Units), 2019-2024
Table 20. By Application - Global Insulin Glargine Injection Sales (K Units), 2025-2030
Table 21. By Region ? Global Insulin Glargine Injection Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Insulin Glargine Injection Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Insulin Glargine Injection Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Insulin Glargine Injection Sales (K Units), 2019-2024
Table 25. By Region - Global Insulin Glargine Injection Sales (K Units), 2025-2030
Table 26. By Country - North America Insulin Glargine Injection Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Insulin Glargine Injection Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Insulin Glargine Injection Sales, (K Units), 2019-2024
Table 29. By Country - North America Insulin Glargine Injection Sales, (K Units), 2025-2030
Table 30. By Country - Europe Insulin Glargine Injection Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Insulin Glargine Injection Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Insulin Glargine Injection Sales, (K Units), 2019-2024
Table 33. By Country - Europe Insulin Glargine Injection Sales, (K Units), 2025-2030
Table 34. By Region - Asia Insulin Glargine Injection Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Insulin Glargine Injection Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Insulin Glargine Injection Sales, (K Units), 2019-2024
Table 37. By Region - Asia Insulin Glargine Injection Sales, (K Units), 2025-2030
Table 38. By Country - South America Insulin Glargine Injection Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Insulin Glargine Injection Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Insulin Glargine Injection Sales, (K Units), 2019-2024
Table 41. By Country - South America Insulin Glargine Injection Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Insulin Glargine Injection Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Insulin Glargine Injection Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Insulin Glargine Injection Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Insulin Glargine Injection Sales, (K Units), 2025-2030
Table 46. Sanofi Company Summary
Table 47. Sanofi Insulin Glargine Injection Product Offerings
Table 48. Sanofi Insulin Glargine Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Sanofi Key News & Latest Developments
Table 50. Lilly Company Summary
Table 51. Lilly Insulin Glargine Injection Product Offerings
Table 52. Lilly Insulin Glargine Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Lilly Key News & Latest Developments
Table 54. Gan & Lee Company Summary
Table 55. Gan & Lee Insulin Glargine Injection Product Offerings
Table 56. Gan & Lee Insulin Glargine Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Gan & Lee Key News & Latest Developments
Table 58. Tonghua Dongbao Pharmaceutical Company Summary
Table 59. Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Product Offerings
Table 60. Tonghua Dongbao Pharmaceutical Insulin Glargine Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Tonghua Dongbao Pharmaceutical Key News & Latest Developments
Table 62. HEC Pharm Company Summary
Table 63. HEC Pharm Insulin Glargine Injection Product Offerings
Table 64. HEC Pharm Insulin Glargine Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. HEC Pharm Key News & Latest Developments
Table 66. Boao Bio Harmaceutical Company Summary
Table 67. Boao Bio Harmaceutical Insulin Glargine Injection Product Offerings
Table 68. Boao Bio Harmaceutical Insulin Glargine Injection Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Boao Bio Harmaceutical Key News & Latest Developments
Table 70. Insulin Glargine Injection Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 71. Global Insulin Glargine Injection Capacity Market Share of Key Manufacturers, 2022-2024
Table 72. Global Insulin Glargine Injection Production by Region, 2019-2024 (K Units)
Table 73. Global Insulin Glargine Injection Production by Region, 2025-2030 (K Units)
Table 74. Insulin Glargine Injection Market Opportunities & Trends in Global Market
Table 75. Insulin Glargine Injection Market Drivers in Global Market
Table 76. Insulin Glargine Injection Market Restraints in Global Market
Table 77. Insulin Glargine Injection Raw Materials
Table 78. Insulin Glargine Injection Raw Materials Suppliers in Global Market
Table 79. Typical Insulin Glargine Injection Downstream
Table 80. Insulin Glargine Injection Downstream Clients in Global Market
Table 81. Insulin Glargine Injection Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Insulin Glargine Injection Segment by Type in 2023
Figure 2. Insulin Glargine Injection Segment by Application in 2023
Figure 3. Global Insulin Glargine Injection Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Insulin Glargine Injection Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Insulin Glargine Injection Revenue, 2019-2030 (US$, Mn)
Figure 7. Insulin Glargine Injection Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Insulin Glargine Injection Revenue in 2023
Figure 9. By Type - Global Insulin Glargine Injection Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Insulin Glargine Injection Revenue Market Share, 2019-2030
Figure 11. By Type - Global Insulin Glargine Injection Sales Market Share, 2019-2030
Figure 12. By Type - Global Insulin Glargine Injection Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Insulin Glargine Injection Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Insulin Glargine Injection Revenue Market Share, 2019-2030
Figure 15. By Application - Global Insulin Glargine Injection Sales Market Share, 2019-2030
Figure 16. By Application - Global Insulin Glargine Injection Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Insulin Glargine Injection Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Insulin Glargine Injection Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Insulin Glargine Injection Revenue Market Share, 2019-2030
Figure 20. By Region - Global Insulin Glargine Injection Sales Market Share, 2019-2030
Figure 21. By Country - North America Insulin Glargine Injection Revenue Market Share, 2019-2030
Figure 22. By Country - North America Insulin Glargine Injection Sales Market Share, 2019-2030
Figure 23. US Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Insulin Glargine Injection Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Insulin Glargine Injection Sales Market Share, 2019-2030
Figure 28. Germany Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 29. France Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Insulin Glargine Injection Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Insulin Glargine Injection Sales Market Share, 2019-2030
Figure 37. China Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 41. India Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Insulin Glargine Injection Revenue Market Share, 2019-2030
Figure 43. By Country - South America Insulin Glargine Injection Sales Market Share, 2019-2030
Figure 44. Brazil Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Insulin Glargine Injection Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Insulin Glargine Injection Sales Market Share, 2019-2030
Figure 48. Turkey Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Insulin Glargine Injection Revenue, (US$, Mn), 2019-2030
Figure 52. Global Insulin Glargine Injection Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Insulin Glargine Injection by Region, 2023 VS 2030
Figure 54. Insulin Glargine Injection Industry Value Chain
Figure 55. Marketing Channels
